Psychosis Program

Our approach to psychosis care

Mass General Brigham offers care across the full continuum, including inpatient, outpatient, residential, home-based, and community-based services. Treatment begins with a comprehensive evaluation of your symptoms, health, and daily life, followed by a personalized care plan.

Care may include:

• Therapy
• Medication
• Group therapy
• Peer support
• Educational and vocational support
• Coordination with other specialists

Psychosis treatment is most effective when tailored to where you are in your experience. Our programs include specialized care for:

• Individuals at risk for psychosis
• First-episode and early psychosis
• Ongoing care and recovery

Some people experience early or mild symptoms that may not develop into a psychotic disorder but still benefit from evaluation and support. These symptoms may also be related to other conditions such as anxiety, trauma, or substance use.

Programs include:

• RE-SET Program (MGH): Team-based outpatient care for adolescents and young adults ages 12-30 who are experiencing changes in their thoughts, feelings, or behavior and may be at risk for psychosis or another serious mental health condition. Services include diagnostic evaluations, individual therapy, and family education and support.
• STAR Program (McLean): Early intervention focused on resilience and functioning

Early treatment can lead to better outcomes.

Programs include:

• FEPP (MGH): Care for individuals ages 14–30 experiencing first-episode psychosis. Referrals are screened to determine whether the program is appropriate. The team may contact you for more information, and submitting a referral does not guarantee treatment.
• OnTrack (McLean): Two-year program for young adults ages 18–30
• Young Adult Mental Health (BWH): Ongoing care for ages 18–26

Long-term care focuses on stability, relapse prevention, and quality of life.

Programs include:

• ROCC (MGH): Care for individuals with stable symptoms
• Schizophrenia and Bipolar Disorders Outpatient Clinic (McLean): Individual and group therapy and medication management for adults ages 18-65 with bipolar or psychotic disorders. Treatment recommendations follow an initial assessment.
• Psychosis Across the Lifespan (PALS) (BWH)

We offer specialized services for evaluation and treatment of complex cases:

• Clozapine Clinic (MGH): Evaluation and treatment with clozapine for people with treatment-resistant schizophrenia.
• Psychosis Consultation Service (MGH): Second opinions to clarify a diagnosis and provide treatment recommendations.
• Outpatient Consultation Service (McLean): Consultations for adults who already have a mental health provider and need diagnostic clarification or guidance about treatment for a psychotic disorder or related mood or anxiety symptoms.
• TRS ACCESS Network (MGH): A network of clinics supporting access to treatment for people with treatment-resistant schizophrenia, including clozapine and long-acting injectable medications.

• Appleton Program (McLean): Residential program focused on independence and recovery
• Program of Assertive Community Treatment (PACT) at McLean: Community-based, at-home support with 24/7 coverage

Our peer-led programs, family support groups, and community-based services provide practical support, education, and connection for individuals and their loved ones:

• Waverley Place (McLean): Peer-led community support
• WellSpace (McLean): Free group activities, vocational support, and individual peer support for young adults ages 18-30 who have experienced psychosis.
• Family Support Group: Weekly virtual support for families

We partner with community organizations to expand access to care:

• MGH Charlestown Community Health Center: Community-based care for people with psychosis and other serious mental health conditions, including treatment consultation, medication services, recovery support, and help connecting with community resources.
• North Suffolk Community Services (Freedom Trail Clinic): Community-based care for people with schizophrenia and other psychotic disorders, including clozapine treatment and long-acting injectable antipsychotics.